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ABSTRACT
This report documents the preparation, homogeneity and stability study as well as the certification
campaign of three lyophilised human whole blood materials, i.e. BCR-634, BCR-635 and BCR-
636 with certified concentrations of lead and cadmium. The homogeneity and stability studies
demonstrated that the materials are homogeneous and stable with respect to storage and
transportation. The materials were subjected to a certification campaign for which the analytical work
is described.
The concentration and uncertainty (expanded uncertainty with a coverage factor of k=2) of lead and
cadmium are
- for BCR-634:   (46 ± 5) µg/L Pb and (1.4 ± 0.4) µg/L Cd;
- for BCR-635: (210 ± 24) µg/L Pb and (6.6 ± 0.6) µg/L Cd;
- for BCR-636: (0.52 ± 0.05)·103 µg/L Pb and (11.6 ± 0.6) µg/L Cd.
IV
ABBREVIATIONS AND SYMBOLS
ASV Anodic Stripping Voltammetry
BCR Community Bureau of Reference
CRM Certified Reference Material
CI Confidence interval
CV Coefficient of Variation
DPASV Differential Pulse Anodic Stripping
Voltammetry
ETAAS Electrothermal Atomic Absorption
Spectrometry
FAAS Flame Atomic Absorption
Spectrometry
ICP-AES Inductively Coupled Plasma Atomic
Emission Spectrometry
ICP-MS Inductively Coupled Plasma Mass
Spectrometry
ISO International Organization for
Standardization
SM&T Standards, Measurements and
Testing
SD Standard deviation
U Uncertainty value
ubb Uncertainty component from
homogeneity
u
*
bb Upper limit of inhomogeneity that
can be hidden by the method
repeatability
uchar Uncertainty component from batch
characterisation
UCRM Expanded uncertainty of CRM
ults Uncertainty component from long-
term stability
usts Uncertainty component from short-
term stability
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71. INTRODUCTION
1.1 Justification and scope of the project
Health and safety at work is an important issue within the European Union. Exposures to toxic
and carcinogenic elements such as lead (Pb) and cadmium (Cd) are considered a major environ-
mental and occupational problem. Such exposure may pose both a short and a long term health risk
to workers and populations at large living in industrial regions.
The EC Directive 80/1107/EEC [1] has been introduced to protect workers from risks related to
exposure to chemical, biological and physical agents. More specific Directives have been introduced
for lead (77/312/EEC and 82/605/EEC [2-3]), for carcinogenic substances (90/394/EEC [4]), and
most recently a Directive (98/24/EC [5]) on chemical agents.
In occupational health, legislation often stipulates threshold limit values for concentrations of chemical
agents in workplace air (i.e. Directive 91/322/EEC on recommended threshold limit values [6]).
However, biological monitoring is a very important tool to assess exposure to chemicals where air
monitoring alone may not be a reliable indicator of exposure, and to assess overall exposure,
occupational and non-occupational, by being a more accurate assessment of the internal dose. When
health risk has to be assessed and actions have to be taken to reduce exposure, reliable data from
measurements for toxic and carcinogenic elements in human tissues and biological fluids are essential.
In this context, the traceability of measurements needs to be documented by the use of certified
reference materials (CRMs). Therefore, the availability of CRMs for trace elements in biological
fluids is of great importance.
The Standards, Measurements and Testing Programme (SM&T, formerly BCR) of the European
Commission has the task to assist in improving the quality of measurements. Therefore a project
dealing with the production of three lyophilised human whole blood reference materials certified for
the contents of Pb and Cd was launched.
The concentrations of Pb and Cd in BCR-634 (low level), BCR-635 (medium level) and BCR-636
(high level) were selected on the basis of the currently accepted values for non- occupationally
exposed individuals and on American Biological Exposure Indices (BEI values) [7] and German
Biologische Arbeitsstoff-Toleranz-Werte (BAT values) [8]. Where no BEI or BAT values exist,
the elevated concentrations were based on data from occupationally exposed workers.
The CRMs will contribute to the harmonisation and comparability of methodological approaches and
measurements of Pb and Cd between different member states, thus enabling economic and political
decisions.
1.2 The certification procedure
The work of certification was co-ordinated by the National Institute of Occupational Health,
Denmark on behalf on the Standards, Measurements and Testing Programme of the European
Commission, Brussels.
After a feasibility study and a preparatory technical meeting in which all the technical requirements
were carefully discussed, the candidate reference materials were produced. The homogeneity and
stability of the materials were documented and the materials were shipped to the laboratories
participating in the certification campaign (see chapter 2). The participants in the certification
campaign all demonstrated satisfactory analytical performance in a preliminary intercomparison
study.
8In the certification campaign each participant was requested to analyse the candidate CRMs under
reproducibility conditions, i.e. analyses performed on different days with different preparations of
calibrants. Furthermore, the participants were requested to submit information on the pre-treatment
of the samples (e.g. digestion procedures etc.), the detection principle (e.g. graphite furnace atomic
absorption spectrometry, inductively coupled plasma mass spectrometry etc.) and detailed
information on the calibration, e.g. the type of calibration (standard additions, matrix-matching
calibrants etc.), the calibrant (reference material, spectroscopic standard etc.), the producer of the
calibrant and the purity of the calibrant.
The different analytical techniques applied in the certification campaign were electrothermal atomic
absorption spectrometry (Zeeman background correction), electrothermal atomic absorption
spectrometry (deuterium background correction), flame atomic absorption spectrometry
(microsampling cup), high resolution inductively coupled plasma mass spectrometry and differential
pulse anodic stripping voltammetry.
The results from the certification campaign were scrutinised at a technical discussion meeting with the
participants and then subjected to a statistical evaluation. The certification is based upon agreement
between the results of the range of different methods applied in the different participating
laboratories.
92. PARTICIPANTS
2.1 Co-ordination, sample preparation, homogeneity and stability studies
- National Institute of Occupational Health, Copenhagen DK
2.2 Analyses
- Analytisch Biochemisch Laboratorium, Assen NL
- Centre for Analytical Sciences, University of Southampton UK
- GSF – National Research Center for Environment and Health
Oberschleissheim DE
- Health & Safety Laboratory, Sheffield UK
- Institut für Arbeits- und Umweltmedizin, Universität München DE
- Institut National de Recherche et de Sécurité, Vandoeuvre FR
- Institute of Occupational Health, University of Brescia IT
- Instituto Nacional de Seguridad e Higiene en el Trabajo, Barakaldo ES
- Istitute Superiore di Sanitá, Rome IT
- National Institute of Occupational Health, Copenhagen DK
- Robens Institute, University of Surrey UK
- Scientific Institute of Public Health, Brussels BE
- Sporstoflaboratoriet, Odense Universitetshospital, Odense DK
- Statens arbeidsmiljøinstitutt, Oslo NO
2.3 Statistical evaluation
- National Institute of Occupational Health, Copenhagen DK
- European Commission, DG JRC, Institute for Reference Materials
and Measurements, Geel BE
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3. PRELIMINARY INVESTIGATIONS
Pilot batches of the lyophilised blood materials were produced in 1996 and a feasibility study
was organised with the participation of 22 laboratories for determination of Pb and/or Cd. The
purpose of the study was to prove the suitability of the materials produced and to identify any
sources of errors in the production and chemical analyses. Furthermore, the pilot batches should
serve as test samples to improve the skills of the participating laboratories for the certification
campaign. For each of three concentration levels of the blood material 300 samples were produced
by the co-ordinator. The low concentration level was representative for an environmental exposure
level, the medium and high levels were comparable to occupational exposure levels.
The results from all laboratories were analysed according to the procedure described in the BCR
Guidelines [9]. Laboratories were excluded from the evaluation according to the following criteria:
- Those laboratories not present at the meeting.
- Those laboratories using an inadequate detection technique.
- Those laboratories using an inadequate calibration technique.
The results were scrutinised for outliers, and technical reasons for suspected outliers were sought. If
no technical reason for the suspect results could be found, the results were retained. No results were
excluded from the evaluation due to statistical reasons only.
3.1 Results of the preliminary intercomparison study
3.1.1 Lead
Ten laboratories used graphite furnace atomic absorption spectrometry (GFAAS) while 5
laboratories used other methods. There was good consistency between the results obtained by
GFAAS and other methods, although Delves cup atomic absorption spectrometry consistently
revealed results a little lower. The calibration techniques were of different types and included
standard additions, matrix matched standards and aqueous standards. When aqueous standards
were used, the standards were checked for parallellity between aqueous and blood standard curves.
The aqueous Pb solutions used for manufacturing the calibration standards were obtained from at
least 9 companies. Some laboratories manufactured their calibration standards from certified
aqueous Pb solutions. This should ensure that the bias in the consensus values due to calibration
should be small.
A summary of the preliminary intercomparison study for Pb in whole blood is presented in table 3.a.
3.1.2 Cadmium
Nine of 12 laboratories with accepted results used GFAAS. Two laboratories using ICP-MS
did not show mutual agreement, while the voltammetric method gave higher results at all three levels.
Thus, it is very difficult to decide if there is any agreement between different techniques.
The variation in calibration techniques and sources of the Cd used for calibration were the same as
for Pb. A summary of the preliminary intercomparison study for Cd in whole blood is presented in
table 3.b.
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Table 3.a Summary of the preliminary intercomparison study for Pb. Target value: The value to
be achieved according to the protocol. Spike: The concentration due to the spike. Consensus
value: The mean of laboratory means of accepted data. Statistical outlier evaluation has not
been performed. 95 % CI : The 95 % confidence interval of the consensus value. Data sets: The
total number of data sets received, and the number of data sets accepted for calculating the
consensus value and confidence interval.
Data setsLevel Target value
(µg/L)
Spike
(µg/L)
Consensus
value,
(µg/L)
95 % CI of
consensus value,
(µg/L)
Total Accepted
Low 35 0 24 21.7 - 25.6 25 13
Medium 200 157 190 186 - 193 26 15
High 500 419 459 442 - 476 26 14
Table 3.b - Summary of the preliminary intercomparison study for Cd. Target value: The value
to be achieved according to the protocol. Spike: The concentration due to the spike. Consensus
value: The mean of laboratory means of accepted data. Statistical outlier evaluation has not
been performed. 95 % CI : The 95 % confidence interval of the consensus value. Data sets: The
total number of data sets received, and the number of data sets accepted for calculating the
consensus value and confidence interval.
Data setsLevel Target value
(µg/L)
Spike
(µg/L)
Consensus
value,
(µg/L)
95 % CI of
consensus value,
(µg/L)
Total Accepted
Low 0.9 0 0.71 0.59 - 0.82 21 12
Medium 5 3.27 3.95 3.65 - 4.26 21 12
High 10 7.63 8.2 7.5 - 8.9 20 12
3.1.3 Conclusion
The outcome of this feasibility study was promising enough to justify a certification campaign
on materials produced with similar concentrations. The laboratories that demonstrated satisfactory
analytical performance in the feasibility study were invited to participate in the certification campaign.
Furthermore, the feasibility study had proved that there was no risk of leaking of Pb and Cd from
neither vials nor stoppers.
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4. PREPARATION OF THE CANDIDATE CRMS
Thirty-five donations of fresh blood were obtained from normal (healthy) Danish blood donors
in October 1996. The individual donations had been tested and found negative for hepatitis B
antigen, and hepatitis C and HIV 1+2 antibodies. Sodiumethylene diaminetetra acetic acid (Na-
EDTA) was used as an anticoagulant to ensure the stability of the liquid phase.
The blood pool was left at room temperature for 10 days in order to ensure complete coagulation.
After filtration through a 0.5 µm Millipore filter, the pool was stirred for 36 hours to obtain a
homogeneous material.
4.1 Spiking
The blood pool was divided into 3 sub-batches each of 5 L. The base (unspiked)
concentration levels of Pb and Cd were measured in order to calculate the amount of metal for the
spiking. The material was spiked according to following scheme:
Table 4.a - Target values and spiking amounts for Pb and Cd content in BCR-634, BCR-635 and BCR-636.
Values in brackets are expected endogenous concentrations.
Lead (Pb) Cadmium (Cd)Reference
Material
Target value
(µg Pb/L)
Spike
(µg Pb/L)
Target value
(µg Cd/L)
Spike
(µg Cd/L)
BCR-634 (50) 0 (< 0.1) 0
BCR-635 200 154 5.0 4.9
BCR-636 500 462 10.0 9.9
Spiking solutions were prepared using NIST SRM 3128 (10.00 ± 0.03 mg Pb/mL) and NIST SRM
3108 (10.00 ± 0.03 mg Cd/mL).
After spiking and homogenisation, 3.0 mL blood was pipetted into each of 1300 brown glass vials.
The variation (CV) of the filling was < 1 %.
4.2 Lyophilisation
Due to a limited volume of the freeze-drier equipment (Hetosicc CD 12 and Hetofrigg), the
freeze drying of each concentration level was performed in two sub-batches in November 1996. In
order to secure a more homogeneous material, each sub-batch was deep-frozen at
- 50 °C overnight before lyophilisation. The frozen material was then transferred to the freeze- drying
equipment and lyophilised for 48 hours under carefully controlled conditions. When the freeze-drying
was completed the vials were sealed automatically under vacuum with butyl stoppers and
encapsulated with an alumina cap.
The candidate CRMs were subsequently stored at -20 °C.
4.3 Residual moisture
The residual moisture content of 10 vials from each CRM was determined by the Joint
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Research Centre, Institute for Reference Materials and Measurements, IRMM, in Geel, Belgium.
The materials were analysed by Karl Fischer titration under dry atmospheric conditions in a glove
box.
The residual moisture was < 2 % for all CRMs, which is sufficient to ensure a stable product without
microbial activity. Therefore, the results (presented in table 4.b) confirm that the lyophilisation has
been adequate.
Table 4.b - Residual moisture contents as mass fraction ( %) determined by Karl Fischer titration
BCR-634 BCR-635 BCR-636
1.50
1.76
1.89
1.85
1.98
1.62
1.61
1.61
1.4
1.86
0.74
0.73
0.81
0.77
0.72
1.96
1.86
1.68
1.93
1.88
1.75
1.73
1.71
1.96
1.82
1.89
1.83
1.84
1.87
1.84
Mean                1.71
SD                    0.19
Mean                1.31
SD                    0.59
Mean                1.82
SD                    0.08
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5. HOMOGENEITY STUDY
The homogeneity study was performed after the filling and lyophilisation process in order to
determine the overall random variation originating from the potential variations during the filling and
the production process.
The homogeneity was examined by analysing 10 vials from each candidate CRM. In order to detect
any sub-batch-to-sub-batch variety originating from the lyophilisation, 5 vials from each sub-batch
were selected randomly at each concentration level and analysed in random order.
5.1 Method
The lyophilised samples were allowed to reach ambient temperature and subsequently
reconstituted by adding 3.000 ± 0.005 mL of Milli-Q water. The added volumes were controlled by
weighing. The stoppers were replaced and the samples were homogenised at continuous agitation on
a mixing apparatus for at least one hour at room temperature. Analysis of Pb and Cd content was
performed by ETAAS (Perkin Elmer 5100-Z or Perkin Elmer SIMAA 6000 ZL). The analyses
were performed as triplicate peak area measurements under repeatability conditions in order to
reduce any analytical variation.
5.2 Results
The variation of Pb and Cd peak area signals was evaluated by analysis of variance,
ANOVA, and the outcome of the statistical evaluation is presented in tables 5a-c. A graphical
survey of the results is presented in Annex I. The between-sample variance estimated in the
ANOVA included both analytical variance and inhomogeneity variance. In case of perfect
homogeneity, the ratio of the between-sample variance and the analytical variance equals 1. The
observed ratio was tested at 5 % significance level.
5.3 Conclusion
For all three candidate CRMs, no statistical significant between-sample or between-sub batch
variation was revealed at the 5 % significance level. The materials were consequently deemed
homogeneous with respect to Pb and Cd contents and judged suitable for certification.
Table 5.a - Homogeneity test of Pb and Cd contents in BCR-634. The material is homogeneous
with respect to Pb and Cd ( P values ≥ 5 %)
Element Source of variation ANOVA estimated variance,  s2 F-test value P-value Mean
BCR-634 Pb Subbatch 0.13 (10.07) 0.48 49.3 %
Samples 0.22 0.72 67.0 %
Analytical method 0.30 - - 10.07
Cd Subbatch 1.20 0.31 58.5 %
Samples 4.75 1.32 29.0 %
Analytical method 3.60 - - 19.63
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Table 5.b - Homogeneity test of Pb and Cd contents in BCR-635. The material is homogeneous
with respect to Pb and Cd ( P values ≥ 5 %)
Element Source of variation ANOVA estimated variance,  s2 F-test value P-value Mean
BCR-635 Pb Subbatch 0.30 0.41 52.6 %
Samples 0.38 0.44 88.1 %
Analytical method 0.87 - - 36.05
Cd Subbatch 0.03 0.01 93.4 %
Samples 3.85 0.76 64.1 %
Analytical method 5.07 - - 70.18
Table 5.c - Homogeneity test of Pb and Cd contents in BCR-636. The material is homogeneous
with respect to Pb and Cd ( P values ≥ 5 %)
Element Source of variation ANOVA estimated variance,  s2 F-test value P-value Mean
BCR-636 Pb Subbatch 0.03 0.01 91.2 %
Samples 1.83 0.60 76.3 %
Analytical method 3.03 - - 91.23
Cd Subbatch 6.53 0.73 40.0 %
Samples 3.53 0.32 95.0 %
Analytical method 11.13 - - 116.52
From these data uncertainty contributions for homogeneity issues were included in the overall
uncertainties of the CRMs. For further details refer to chapter 8.
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6. STABILITY STUDY
The stability of the candidate CRMs was evaluated in a long-term stability study and an
accelerated degradation stability study at elevated temperatures.
6.1 Long-term stability study
The long-term stability was assessed by analysing 3 samples from each candidate CRM stored
at – 20 °C at two occasions (July 1997 and November 1997).
6.1.1 Method
The samples were analysed by ETAAS (Perkin Elmer 5100-Z or Perkin Elmer SIMAA 6000
ZL) using calibration standards prepared by spiking human whole blood with NIST SRM 3128
(10.00 ± 0.03 mg Pb/mL) and NIST SRM 3108 (10.00 ± 0.03 mg Cd/mL) to appropriate
concentrations. Statistical control of the analytical procedure was documented by the use of control
charts. Analysis of BCR-194 and BCR-195 (Lead and Cadmium in Lyophilised Blood) and
participation in proficiency testing schemes served to detect the emergence of bias problems.
6.1.2 Results
Any change of concentration with time indicates instability of the materials provided that a
good analytical reproducibility has been achieved. Instability is detected by comparing the means of
the measured contents of Pb and Cd at the two study occasions using ANOVA. Results from the
ANOVAs are presented in the tables 6.a-c.
Table 6.a - Long-term stability test of  Pb and Cd contents in BCR-634. The material is stable
with respect to Pb and Cd ( P values ≥ 5 %)
Element Source of variation ANOVA estimated variance,  s2 F-test value P-value
BCR-634 Pb Time 4.00 1.26 32.5 %
Samples 3.18 - -
Cd Time 0.0096 2.11 22.0 %
Samples 0.0045 - -
Table 6.b - Long term stability test of Pb and Cd contents in BCR-635. The material is stable with
respect to Pb and Cd ( P values ≥ 5 %)
Element Source of variation ANOVA estimated variance,  s2 F-test value P-value
BCR-635 Pb Time 134.43 5.40 8.1 %
Samples 24.88 - -
Cd Time 0.0504 2.80 17.0 %
Samples 0.0180 - -
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Table 6.c - Long term stability test of Pb and Cd contents in BCR-636. The material is stable with
respect to Pb and Cd ( P values ≥ 5 %)
Element Source of variation ANOVA estimated variance,  s2 F-test value P-value
BCR- 636 Pb Time 423.36 2.41 19.5 %
Samples 175.47 - -
Cd Time 0.0600 4.62 9.8 %
Samples 0.0130 - -
6.1.3 Conclusion
For all three candidate CRMs, no statistical significant variation was revealed between the two
study occasions at the 5 % significance level. The materials were consequently deemed stable with
respect to  Pb and Cd contents and judged suitable for certification. An estimate for the uncertainty
related to stability, ults, was included in the uncertainty budget. This allowance will be used to
establish an expiry date of the certificate. For long-term storage a temperature of –20 °C was
envisaged.
6.2 Accelerated degradation stability study
The accelerated degradation stability study started in February 1997 with a duration of 24
weeks. In the study, samples were exposed to various degrees of thermal stress by storage at 3
different temperatures: 20 °C, 37 °C and 45 °C. The reference temperature was -80 °C. At
representative time intervals (4, 12 and 24 weeks, respectively, after the start of the study) samples
were taken out and brought to the reference temperature. At the end of the study, all samples (3
samples from each of 3 concentration levels, exposed to 3 different temperatures, for 3 time
intervals) were brought to room temperature and analysed together with 3 samples kept at the
reference temperature during the whole study period.
6.2.1 Method
The samples were analysed by ETAAS (Perkin Elmer 5100-Z or Perkin Elmer SIMAA 6000
ZL). The analyses were performed as peak area measurements under repeatability conditions in
order to reduce any analytical variation. The mean sample signal of the samples exposed to thermal
stress was compared to the mean signal of the samples kept at the reference temperature. The target
value of the ratio of the means is 1 (exactly). 95 % confidence intervals are calculated for the ratios,
and it is considered as an indication of thermal instability if the target value is outside the confidence
interval.
6.2.2 Results
Results from the accelerated degradation study are presented in figures 6.1-3 on the following
pages. On the basis on the analyses of the reference samples and the samples subjected to thermal
stress, no statistically significant difference could be detected for BCR- 634, BCR-635 or BCR-636
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at the 5 % significance level. For Pb in BCR-636, a significant increase in the ratio (peak area at test
temp./peak area at ref. temp.) for the samples stored at 20 °C for 12 weeks was observed.
However, after 24 weeks the ratio has returned to the normal level with the CI including the value 1.
6.2.3 Conclusion
The results indicate that the materials have a sufficient resistance to thermal stress.
Consequently, no special efforts with respect to temperature have to be taken at transportation of the
materials.
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Figure 6.1 - Accelerated degradation study. Determinations of Pb and Cd in BCR-634 at three
different time intervals. Ratio (test temp./ref. temp.) is the ratio of the peak area obtained at the
test temperature and the peak area obtained at the reference temperature.
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Figure 6.2 - Accelerated degradation study. Determinations of Pb and Cd in BCR- 635 at three
different time intervals. Ratio (test temp./ref. temp.) is the ratio of the peak area obtained at the
test temperature and the peak area obtained at the reference temperature.
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Figure 6.3 - Accelerated degradation study. Determinations of Pb and Cd in BCR-636 at three
different time intervals. Ratio (test temp./ref. temp.) is the ratio of the peak area obtained at the
test temperature and the peak area obtained at the reference temperature.
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7. CERTIFICATION MEASUREMENTS
The participants in the certification campaign were invited as a consequence of a successful
participation in the feasibility study. Each participant was requested to read and complete a detailed
protocol for quality assurance giving detailed information about the reconstitution of the samples,
accuracy of the volumetric equipment used for sampling and in the measurement procedure, the
calibrants used and the applied analytical procedure. Furthermore, the participants had to document
and formally guarantee that the measurements were performed with the analytical procedure in
statistical control, i.e.
- no bias was detectable;
- the reproducibility was consistent with what the laboratory was able to achieve under the best
circumstances.
Special emphasis was on the traceability of the measurements, i.e. the identity, purity and
stoichiometry of the substances used for preparation of the calibrants. Acceptable calibrants were:
- A pure substance, weighed and dissolved by the participant. Stoichiometry was verified by
checking the working standards against another fresh gravimetrically prepared standard.
- A certified material of the substance in simple solution (i.e. not a matrix certified material),
provided that the uncertainty of the certified value is consistent with its use as a calibrant. The
certified value was checked against a fresh gravimetrically prepared standard.
- Other substances, either pure or in simple solution, traceable to the types of materials
mentioned above. The traceability chain was documented. Matrix reference materials were not
allowed as calibrants.
The participants had formally to guarantee and be able to provide evidence that the traceability in the
measurements was ensured. The results from the certification campaign accepted on technical and
statistical ground are presented in Annex II. Each set of results is identified by a Lab ID code and
details on the analytical procedures and calibrants used are given in chapter 7.1.
7.1 Analytical methods
Three different analytical principles (AAS, ASV and ICP-MS) were applied in the certification
campaign each of them being highly selective for the measurands. The method diversity therefore
ensures the credibility of the certified values. In table 7.a-b, the analytical techniques from the
certification measurements are listed. In table 7.c-d, the calibrants used by the participants are listed.
7.2 Technical evaluation of the results
To obtain the accuracy that is required for certification it is necessary to ensure that no
substantial systematic error is left undetected. Therefore, each set of data was thoroughly scrutinised
at a technical meeting with participation of the laboratories.
Table 7.a - Analytical techniques applied in the certification campaign for Pb in BCR-634, BCR-
635 and BCR-636
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Measurand LAB
ID
Method Sample pretreatment Detection
Lead 1 FAAS2 Dry, partly oxidised with H2O2 in Ni-cup: 10 µL sample are
dried on on hot-plate, 20 µL 10 % H2O2  added dried for
further 5 min.
Flame atomic absorption,
microsampling cup
Deuterium background corr.
Lead 2 AAS1 10 µL sample + 10 µL diluent/spike + 5 µL  1 % (NH4)2HPO4
Dilution 1+4 v/v or 1+5 v/v with 0.025 M (NH4)2HPO4 in 1 %
NH4OH
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Lead 4 ASV1 Low + medium level:1.5 mL sample +3.0 mL HNO3 + 0.4 mL
HClO4
High level: 0.5 mL sample + 1.5 mL HNO3 + 0.25 mL HClO4
Digested at 320 °C and evaporated until dryness. Reconstituted
with 1.0 mL H2O + 0.4 mL HCl (high level 0.2 mL HCl) +
H2O ad 10.0 mL.
Differential pulse anodic stripping
voltammetry, DPASV
Lead 4 ICP2 Low + medium level:1.5 mL sample +3.0 mL HNO3 + 0.4 mL
HClO4
High level: 0.5 mL sample + 1.5 mL HNO3 + 0.25 mL HClO4
Digested at 320 °C and evaporated until dryness. Reconstituted
with 1.0 mL H2O + 0.4 mL HCl (high level 0.2 mL HCl) +
H2O ad 10.0 mL.
High resolution ICP-MS
206Pb, 208Pb
Resolution: 300
Internal standard:193Ir
Lead 5 AAS1 100 µL sample diluted with 900 µL 0.2 % Triton X-100 ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Lead 7 AAS1 Dilution 1+10  with modifier 2 % (NH4)2HPO4 + 0.2 % Triton
X-100
ETAAS with Zeeman background
correction,
pyrocoated furnace with platform
Lead 13 AAS1 Samples diluted 1+ 4 with 0.2 % Triton X-100
modifier:  0.5 g/L Mg(NO3)2 +  5 g/L NH4H2PO4
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Lead 19 AAS2 Samples diluted 1+12 with 1 % NH4H2PO4 + 0.1 % Triton X-
100
ETAAS with deuterium background
correction
pyrocoated furnace with platform
Lead 20 AAS2 30 µL sample diluted with 420 µL modifier :
0.05 % Triton X-100 + 7 g/L (NH4)2HPO4
ETAAS with deuterium background
correction
pyrocoated furnace
Lead 26 AAS1 2.0 mL sample digested with 2.5 mL sub-distilled HNO3.
Solution made up to 10.0 mL with H2O
ETAAS with Zeeman background
correction
Z-tek-tubes
Lead 31 AAS1 100 µL sample diluted with 100 µL standard and 300 µL
modifier
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Lead 43 AAS2 Deproteinization with acid ETAAS with deuterium background
correction
pyrocoated furnace
Lead 56 AAS1 Dilution 1:10 ETAAS with Zeeman background
correction
graphite furnace with platform
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Table 7.b - Analytical techniques applied in the certification campaign for Cd in BCR-634, BCR-
635 and BCR-636
Measurand LAB
ID
Method Sample pre-treatment Detection
Cadmium 2 AAS1 10 µL sample + 10 µL diluent/spike + 5 µL  1 % (NH4)2HPO4
Dilution 1+4 v/v or 1+5 v/v with 0.025 M (NH4)2HPO4 in
1 % NH4OH
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Cadmium 4 ASV1 Low + medium level:1.5 mL sample +3.0 mL HNO3 + 0.4
mL HClO4
High level: 0.5 mL sample + 1.5 mL HNO3 + 0.25 mL HClO4
Digested at 320 °C and evaporated until dryness.
Reconstituted with 1.0 mL H2O + 0.4 mL HCl (high level 0.2
mL HCl) + H2O ad 10.0 mL.
Differential pulse anodic stripping
voltammetry, DPASV
Cadmium 4 ICP2 Low + medium level:1.5 mL sample +3.0 mL HNO3 + 0.4
mL HClO4
High level: 0.5 mL sample + 1.5 mL HNO3 + 0.25 mL HClO4
Digested at 320 °C and evaporated until dryness.
Reconstituted with 1.0 mL H2O + 0.4 mL HCl (high level 0.2
mL HCl) + H2O ad 10.0 mL.
High resolution ICP-MS
114Cd
Resolution: 300
Internal standard: 103Rh
Cadmium 5 AAS1 100 µL sample is diluted with 400 µL (NH4)2HPO4 solution
with
2 % Triton X-100
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Cadmium 7 AAS1 Dilution 1+10  with modifier 2 % (NH4)2HPO4 + 0.2 %
Triton X-100
ETAAS with Zeeman background
correction,
pyrocoated furnace with platform
Cadmium 13 AAS1 Samples diluted 1+ 3 with 2 % Triton X-100
modifier:  0.5 g/L Mg(NO3)2 +  5 g/L NH4H2PO4
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Cadmium 15 AAS1 Samples diluted fivefold with diluent/modifier: 5g/L Triton X-
100 +  50 g/L (NH4)2HPO4
ETAAS with Zeeman background
correction
pyrocoated furnace with platform
Cadmium 26 AAS1 2.0 mL sample digested with 2.5 mL sub-distilled HNO3 .
Solution made up to 10.0 mL with H2O
Modifier: 0.1 % Pd
ETAAS with Zeeman background
correction
Z-tek-tubes
Cadmium 56 AAS1 Dilution 1:10 ETAAS with Zeeman background
correction
graphite furnace with platform
Cadmium 63 AAS1 Dilution with Triton X-100 1:5 to 1:10
Modifier: Pd(NO3)2
ETAAS with Zeeman background
correction
graphite furnace
7.3 Statistical evaluation of the results
For each data set from the certification campaign (presented in Annex II) the mean value and
the standard deviation were calculated. Each set in the evaluation reports has passed the technical
scrutiny. After the technical scrutiny, the results were subjected to appropriate statistical techniques:
- Kolmogorov-Smirnov-Lilliefors test to assess the conformity of the distributions of the
laboratory mean values to normal distribution;
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- Cochran’s test for detecting outlying laboratory variances;
- Grubb’s test for detecting outlying laboratory mean values;
- Bartletts test to check the homogeneity of the laboratory variances;
- One way ANOVA (F-test) to compare and estimate the between and the within
laboratory components of the overall variance of all individual results.
For the Cochran and Grubb tests, a value is called an outlier if it is rejected with a 1 % risk of error.
If the risk lies between 1 % and 5 %, the values is called “a straggler” and it can be included in the
calculation of the values for certification if it overlaps with the results from the same analytical
principle.
The ANOVA showed that the between laboratory variation contributes considerably to the overall
variability of the results and, consequently, the laboratory means were used for calculating the values
for certification. A summary of the statistical evaluation of each CRM is presented in Tables 7.e-g.
Details of the individual results from the certification campaign are presented in Annex II.
Table 7.c - Calibrants used in the certification campaign for Pb in BCR-634, BCR-635 and BCR-
636
Measurand LAB ID Method Type of calibration Calibrant Producer Purity
Lead 1 FAA2 Matrix matching
standards
(bovine blood)
Lead standard solution no. 2291 Fisons 1000 µg /mL
Lead 2 AAS1 Standard addition,
Instrument automated
PE Pure GFAAS Mixed standard
Spectroscan AAS Standards 8017
Perkin Elmer
Technolab A/S
100 ± 0.04 µg
Pb/mL
1000 ± 3 mg Pb/L
Lead 4 ASV Standard addition Spex plasma standard, Pb PLPB2-
24
Spex Ind.USA 1000 µg /mL ±
0.2 %
Lead 4 ICP2 Standard curve Spex plasma standard, Pb PLPB2-
24
Spex Ind.USA 1 g /L ± 0.2 %
Lead 5 AAS1 Standard addition
Low level: standard
curve, aqueous
standards
 Lead AA std. solution no. 88075 ALFA Johnson
Matthey
Company
1000 µg /mL
Lead 7 AAS1 Standard curve,
matrix matching
standards
SRM 3128 NIST 10.00 ± 0.03
mg/mL
Lead 13 AAS1 Standard curve,
matrix-matching
standards
Pb standard AA solution Merck 1.000 ± 0.002 g/L
Lead 19 AAS1 Standard curve,
aqueous standards
Pb single element plasma emission
sol.,
Perkin Elmer 999 µg/mL ± 0.5 %
Lead 20 AAS1 Standard curve,
matrix-matching
standards
Spectrosol Pb sol. no. 140362D Merck 1000 ± 2 mg/L
Lead 26 AAS1 Standard curve,
matrix-matching
standards
Pb, no. 8017-2 Teknolab A/S 1000 ± 3 µg/mL
Lead 31 AAS1 Standard addition Pb single element plasma emission
sol.,
Perkin Elmer 1000 µg/mL ±
0.5 %
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Lead 43 AAS2 Standard curve Pb solution, no. 1.19776 Merck 1002 ± 2 mg/L
Lead 56 AAS1 Standard addition Lead standard solution Analyticals
CARLO ERBA
1 mg/mL
Table 7.d - Calibrants used in  the certification campaign for Cd in BCR-634, BCR-635 and
BCR-636
Measurand LAB ID Method Type of calibration Calibrant Producer Purity
Cadmium 2 AAS1 Standard addition,
Instrument automated
PE Pure GFAAS Mixed standard
Titrisol AAS-ICP
Perkin Elmer
Merck
5 ± 0.05 µg /mL
1000  ± 2 mg /L
Cadmium 4 DPASV Standard addition Spex plasma standard, Cd
PLCD2-24
Spex Ind.USA 1000 µg /mL ±
0.2 %
Cadmium 4 ICP2 Standard curve Spex plasma standard, Cd
PLCD2-24
Spex Ind.USA 1000 µg /mL ±
0.2 %
Cadmium 5 AAS1 Standard addition Cadmium AA std. solution no.
88056
ALFA Johnson
Matthey Company
1000  µg /mL
Cadmium 7 AAS1 Standard curve, Matrix
matching standards
SRM 3108 NIST 10.00 ± 0.03 mg
/mL
Cadmium 13 AAS1 Standard curve, Matrix-
matching standards
Cd standard AA solution Merck 1.000  ± 0.002 g/L
Cadmium 15 AAS1 Standard addition,
matrix matching
standards
Cadmium standard solution,
ref.1.19777.500
Merck-Clevenot
lab.
1000 ± 2 mg/L
Cadmium 26 AAS1 Standard curve, Matrix-
matching standards
Cd, no. 8014-1 Teknolab A/S 1000 ± 3 µg/mL
Cadmium 56 AAS1 Standard addition Cadmium standard solution Analyticals
CARLO ERBA
1 mg/mL
Cadmium 63 AAS1 Standard curve,
Aqueous standards
PLCD2-24 SPEX 1002 µg/mL ±
0.5 %
Table 7.e - Summary of statistical data for BCR-634
Certified property Pb Cd
Number of data sets 12 10
Number of individual data 60 50
Outlying data sets (Grubbs test) No No
Outlying variances (Cochran test) No No
Mean of data set means 46.21 µg/L 1.36 µg/L
Within-data set SD 2.64 µg/L 0.11 µg/L
Between-data set SD 1.67 µg/L 0.07 µg/L
Variances homogeneous  (Bartlett test) No Yes
SD of data set means 2.05 µg/L 0.07 µg/L
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Data set means normally distributed
(Kolmogorov-Smirnov-Lilliefors test)
Yes Yes
Half width of the 95 % CI of the mean of data set means 1.30 µg/L 0.06 µg/L
Table 7.f - Summary of statistical data for BCR-635
Certified property Pb Cd
Number of data sets 12 9
Number of individual data 60 45
Outlying data sets (Grubbs test) No
(one straggler)
No
Outlying variances (Cochran test) No
(one straggler)
Yes (1 outlier detected)
Mean of data set means 209.83 µg/L 6.55 µg/L
Within-data set SD 5.91 µg/L 0.17 µg/L
Between-data set SD 8.69 µg/L 0.15 µg/L
Variances homogeneous  (Bartlett test) Yes Yes
SD of data set means 9.09 µg/L 0.17 µg/L
Data set means normally distributed
(Kolmogorov-Smirnov-Lilliefors test)
Yes Yes
Half width of the 95 % CI of the mean of data set means 5.77 µg/L 0.14 µg/L
Table 7.g - Summary of statistical data for BCR-636
Certified property Pb Cd
Number of data sets 11 9
Number of individual data 55 45
Outlying data sets (Grubbs test) No No
Outlying variances (Cochran test) No Yes (1 outlier detected)
Mean of data set means 515.33 µg/L 11.64 µg/L
Within-data set SD 12.11 µg/L 0.35 µg/L
Between-data set SD 15.08 µg/L 0.35 µg/L
Variances homogeneous  (Bartlett test) Yes Yes
SD of data set means 16.02 µg/L 0.38 µg/L
Data set means normally distributed
(Kolmogorov-Smirnov-Lilliefors test)
Yes Yes
Half width of the 95 % CI of the mean of data set means 10.76 µg/L 0.29 µg/L
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8. CERTIFIED VALUES AND UNCERTAINTY EVALUATION
8.1 Uncertainty evaluation
The evaluation of uncertainties was done in compliance with the requirements made by GUM
[10]. According to these requirements, the various uncertainty sources such as stability, homogeneity
and batch characterisation (certification campaign) need to be properly estimated.
The evaluation described hereafter is based on a concept described by Pauwels et al. [11 and
literature cited] and uses available data discussed in the previous chapters.
8.1.1 Introduction and statistical concept
In order to be complete, the combined (and expanded) standard uncertainty on a reference
material should consider that in addition to the characterisation of the batch, homogeneity, and long-
and short-term stability play an important role. Therefore, the uncertainty can be expressed as:
- Uncertainty of the certified value as obtained for the batch (characterisation, uchar);
- Transferred to a single package (homogeneity, ubb);
- As dispatch to the customer (short-term stability, usts);
- At the time of sale (long-term stability, ults).
Following this and based on the data obtained in the stability and homogeneity studies as well
as the results of the batch characterisation, estimates for ubb (homogeneity), ults (long-term-stability)
and uchar (batch characterisation) were obtained and combined according the following equation [11
and literature cited]:
2222 charltsbbCRM uuuU ++⋅=
Due to the transport conditions selected for dispatch, the uncertainty constituent for short-term
stabililty (usts) is negligible and consequently not included in the overall uncertainty. The estimation of
the other uncertainty sources is described below.
8.1.2 Uncertainty source “homogeneity”
The homogeneity study is exhaustively described in chapter 5 and results have been evaluated by
means of a ANOVA. Using the variances described in Tables 5a-b, estimates of ubb were derived as
described by Linsinger et al. [12]. According to this approach, sbb (being the standard deviation
between units) or u*bb (being the upper limit of inhomogeneity that can be hidden by the method
repeatability) are used as estimates of ubb. To this end values for u*bb and sbb were calculated
accordingly:
4
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where n is the number of replicates per unit, νMSwithin the degrees of freedom of MSwithin (ANOVA
estimated variance for 3 replicates, Table 5a-c);
and
n
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n
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s
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samples
withinbetween
bb
2
2
−=
−
=
where MSbetween is the ANOVA estimated variance on 10 samples (Table 5a-c).
As a principle, the respective higher value of sbb or u*bb is adopted as ubb and included in the
expanded uncertainty. The results of these calculations are shown in Tables 8a-c.
8.1.3 Uncertainty source “stability”
The stability data discussed in chapter 6 are sufficient to deem the material to be stable.
However, they do not allow the establishment of a shelf-life. In order to obtain a reasonable estimate
of the related uncertainty component ults, the ANOVA data of Table 7e-g were used.
First, a rough estimate for ults was derived evaluating the ANOVA data as simple homogeneity study
and using the respective sbb-value (see equation above). The obtained values were then divided by
the mean values of the certification experiments in order to obtain an expression in percentage. These
data are compiled in Tables 8a-c.
8.1.4 Uncertainty source “batch characterisation”
An estimate for uchar was derived from the standard error obtained on the mean of laboratories
means.
8.1.5 Uncertainty budget
Based on the uncertainty contributions mentioned in sections above the following uncertainty
budgets are established:
Table 8.a – Uncertainty budget and certified values for BCR-634
Pb Cd
ubb (sbb) [in rel. %] 3.4 9.6
u
*
bb [in rel. %] 2.1a 3.7 a
ults [in rel. %] 3.7 6.6
uchar [in rel. %] 1.3 1.6
coverage factor k 2 2
UCRM [in rel. %] 10.4 23.5
Mean [in µg/L] 46.21 1.36
Uncertainty [in µg/L] 4.81 0.32
Certified values expressed
in µg/L 46 ± 5 1.4 ± 0.4
a
 not used for combined uncertainty
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Table 8.b – Uncertainty budget and certified values for BCR-635
Pb Cd
ubb (sbb) [in rel. %] 0.8a 2.1
u
*
bb [in rel. %]a 1.0 1.2a
ults [in rel. %] 5.4 3.2
uchar [in rel. %] 1.3 0.9
coverage factor k 2 2
UCRM [in rel. %] 11.3 7.9
Mean [in µg/L] 209.83 6.55
Uncertainty [in µg/L] 23.71 0.52
Certified values expressed
in µg/L 210 ± 24 6.6 ± 0.6
a
 not used for combined uncertainty
Table 8.c – Uncertainty budget and certified values for BCR-636
Pb Cd
ubb (sbb) [in rel. %] 1.0 b
u
*
bb [in rel. %]a 0.7a 1.1
ults [in rel. %] 3.7 2.0
uchar [in rel. %] 0.9 1.1
Coverage factor k 2 2
UCRM [in rel. %] 7.9 5.1
Mean [in µg/L] 515.33 11.64
Uncertainty [in µg/L] 40.71 0.59
Certified values and
expressed in µg/L (0.52 ± 0.05)·10
3 11.6 ± 0.6
a
 not used for combined uncertainty
b
 not calculable
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8.2 Certified values
The certified values (unweighed mean of the accepted sets of results) and their uncertainties
(expanded uncertainty with a coverage factor of k=2)) are summarised in tables 8.a-c.
Table 8.d - Certified values for Pb and Cd in BCR-634, expressed in reconstituted sample
BCR-634
Component
Certified content,
µg/L
Uncertainty,
µg/L
Number of accepted sets of results
Lead, Pb 46 5 12
Cadmium, Cd 1.4 0.4 10
Table 8.e - Certified values for Pb and Cd in BCR-635, expressed in reconstituted sample
BCR-635
Component
Certified content,
µg/L
Uncertainty,
µg/L
Number of accepted sets of results
Lead, Pb 210 24 12
Cadmium, Cd 6.6 0.6 9
Table 8.f - Certified values for Pb and Cd in BCR-636, expressed in reconstituted sample
BCR- 636
Component
Certified content,
µg/L
Uncertainty,
µg/L
Number of accepted sets of results
Lead, Pb 0.52·103 0.05·103 11
Cadmium, Cd 11.6 0.6 9
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9. INSTRUCTIONS FOR USE
9.1 Description
Samples of BCR-634, BCR-635 and BCR-636 consist of lyophilised human whole blood.
Each unit contains approximately 0.6 g dry matter with a residual moisture content of less than 2 %.
Sodium-EDTA was used as anti-coagulant. No further preservatives are added.
9.2 Storage conditions
Unopened vials should be stored at -20°C or lower for long-term storage.
9.3 Reconstitution
Before use the following instructions for reconstitution are to be executed:
1. Allow the vial to reach ambient temperature before opening.
2. Tap the bottom of the vial to loosen any blood material adhering to the stopper.
3. Carefully remove the rubber stopper.
4. Add 3.00 mL water (room temperature). Acceptable CV = 0.5 %
5. Replace rubber stopper and homogenise by continuous agitation on a mixing
apparatus for at least 1 h.
9.4 Safety
The materials were produced from blood from healthy Danish blood donors. Each portion of
blood was tested negative for Anti-HIV-1&2, Anti-HCV and Anti-HTLV-I&II. However, as all
biological material of human origin the blood should be treated as contagious material. The materials
are for in vitro use only.
9.5 Use of the certified value and uncertainty
If the reference material is used for checking an analytical procedure or for evaluation of the
performance of the procedure, the user can refer to the results from the certification campaign after
having ascertained that the repeatability of the method is satisfactory.
The user may assess the bias of the method from the difference between the mean value of replicate
measurements (x) and the certified value (µ). The following general criterion for acceptance is given
in ISO Guide 33 [14]:
-a2  - 2 σL < x - µ < a1  + 2 σL
in which a1 and a2 are adjustment values chosen by the user according to economic or technical
limitations or stipulation, and σL is the long-term-within laboratory standard deviation (reproducibility
SD) of the method (e.g. as determined during a method evaluation and used for setting acceptance
limits in a control chart).
Matrix reference materials like BCR- 634, BCR-635 and BCR-636 should not be used for
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calibration due to possible differences in matrix between calibrant and sample.
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11. ANNEX I – GRAPHICAL PRESENTATION OF THE HOMOGENEITY STUDY
11.1 Graphical survey of the results from the homogeneity study on BCR-634
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Figure 11.1 - Means and confidence intervals (CI) for the results of Pb determination in
individual samples of BCR-634
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Figure 11.2 - Means and confidence intervals (CI) for the results of Cd determination in
individual samples of BCR-634
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11.2 Graphical survey of the results from the homogeneity study on BCR-635
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Figure 11.3 - Means and confidence intervals (CI) for the results of Pb determination in
individual samples of BCR-635
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Figure 11.4 - Means and confidence intervals (CI) for the results of Cd determination in
individual samples of BCR-635
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11.3 Graphical survey of the results from the homogeneity study on BCR-636
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Figure 11.5 - Means and confidence intervals (CI) for the results of Pb determination in
individual samples of BCR-636
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Figure 11.6 - Means and confidence intervals (CI) for the results of Cd determination in
individual samples of BCR-636
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12. ANNEX II – CERTIFICATION CAMPAIGN: TABLES OF INDIVIDUAL
RESULTS AND GRAPHICAL PRESENTATION
Table 12.a - Table of individual results for BCR- 634, Pb (µg/L)
Lab ID Method Individual measurement results Mean Std. Dev. CV %
L1 FAAS2 48.00 50.00 49.00 41.00 46.00 46.800 3.564 7.6
L2 AAS1 42.40 41.70 43.30 42.90 40.80 42.220 0.993 2.4
L4 ASV1 46.10 47.00 47.50 48.60 44.50 46.740 1.544 3.3
L4 ICP2 46.80 47.10 45.30 45.50 45.80 46.100 0.803 1.7
L5 AAS1 47.15 45.20 46.55 43.90 45.20 45.600 1.276 2.8
L7 AAS1 47.10 47.30 50.00 45.00 40.20 45.920 3.657 8.0
L13 AAS1 47.00 49.00 47.00 53.00 57.00 50.600 4.336 8.6
L20 AAS2 41.40 47.70 47.70 43.50 41.40 44.340 3.185 7.2
L26 AAS1 48.00 45.80 46.10 44.50 48.10 46.500 1.538 3.3
L31 AAS1 48.21 46.65 48.27 49.02 47.97 48.024 0.863 1.8
L43 AAS2 40.76 42.04 45.30 45.18 50.14 44.684 3.633 8.1
L56 AAS1 45.00 47.00 50.00 44.00 49.00 47.000 2.550 5.4
Means and 95% confidence intervals (CI)
µg/L
Method   LabId
  AAS1     L31
  AAS1      L2
  AAS1     L56
  AAS1     L26
  AAS1      L5
  AAS1      L7
  AAS1     L13
  AAS2     L20
  AAS2     L43
  ASV1      L4
 FAAS2      L1
  ICP2      L4
[Means]   
30 33 36 39 42 45 48 51 54 57 60 63 66
Figure 12.1 - Graphical presentation of individual results BCR- 634, Pb (µg/L)
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Table 12.b - Table of individual results for BCR- 634, Cd (µg/L)
Lab ID Method Individual measurement results Mean Std. Dev. CV %
L2 AAS1 1.16 1.38 1.24 1.30 1.40 1.296 0.099 7.7
L4 ASV1 1.30 1.30 1.50 1.20 1.30 1.320 0.110 8.3
L4 ICP2 1.30 1.50 1.60 1.40 1.50 1.460 0.114 7.8
L5 AAS1 1.40 1.30 1.50 1.30 1.30 1.360 0.089 6.6
L7 AAS1 1.53 1.46 1.58 1.38 1.45 1.480 0.077 5.2
L13 AAS1 1.29 1.30 1.58 1.21 1.15 1.306 0.165 12.6
L15 AAS1 1.19 1.34 1.26 1.28 1.26 1.266 0.054 4.2
L26 AAS1 1.24 1.19 1.27 1.24 1.35 1.258 0.059 4.7
L56 AAS1 1.40 1.50 1.30 1.50 1.60 1.460 0.114 7.8
L63 AAS1 1.20 1.50 1.50 1.40 1.40 1.400 0.122 8.7
Means and 95% confidence intervals (CI)
µg/L
Method   LabId
  AAS1      L2
  AAS1     L56
  AAS1     L63
  AAS1      L5
  AAS1      L7
  AAS1     L13
  AAS1     L15
  AAS1     L26
  ASV1      L4
  ICP2      L4
[Means]   
0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9
Figure 12.2 - Graphical presentation of individual results BCR- 634, Cd (µg/L)
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Table 12.c - Table of individual results for BCR- 635, Pb (µg/L)
Lab ID Method Individual measurement results Mean Std. Dev. CV %
L1 FAAS2 219.00 209.00 211.00 215.00 209.00 212.600 4.336 2.0
L2 AAS1 191.10 194.00 192.90 186.90 174.20 187.820 8.079 4.3
L4 ASV1 226.00 216.00 206.00 226.00 214.00 217.600 8.532 3.9
L4 ICP2 221.00 213.00 205.00 218.00 211.00 213.600 6.229 2.9
L5 AAS1 215.00 222.00 221.00 215.00 217.50 218.100 3.286 1.5
L7 AAS1 213.60 204.40 199.80 199.10 197.30 202.840 6.560 3.2
L13 AAS1 217.00 220.00 207.00 215.00 217.00 215.200 4.919 2.3
L19 AAS2 200.00 200.00 205.00 199.00 206.00 202.00 3.240 1.6
L20 AAS2 215.50 217.60 217.60 213.40 213.40 215.500 2.100 1.0
L26 AAS1 215.00 192.00 208.00 218.00 199.00 206.400 10.877 5.3
L31 AAS1 207.05 202.38 207.48 208.81 221.00 207.344 3.173 1.5
L56 AAS1 218.00 217.00 220.00 219.00 221.00 219.000 1.581 0.7
Means and 95% confidence intervals (CI)
µg/L
Method   LabId
  AAS1     L31
  AAS1      L2
  AAS1     L56
  AAS1     L26
  AAS1      L5
  AAS1      L7
  AAS1     L13
  AAS2     L20
  AAS2     L19
  ASV1      L4
 FAAS2      L1
  ICP2      L4
[Means]   
170 175 180 185 190 195 200 205 210 215 220 225 230 235 240
Figure 12.3 - Graphical presentation of individual results BCR- 635, Pb (µg/L)
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Table 12.d - Table of individual results for BCR- 635, Cd (µg/L). Numbers in square
parantheses,“[]”, are statistically found outliers (significance level 1 %). They take part in the
Lillifors-test for normality and are shown in the graphs, but are ignored in all other
calculations.
Lab ID Method Individual measurement results Mean Std. Dev. CV %
L2 AAS1 6.40 6.90 6.23 6.60 6.72 6.570 0.263 4.0
L4 ASV1 6.50 6.30 6.50 6.40 6.20 6.380 0.130 2.0
L4 ICP2 6.20 6.40 6.40 6.50 6.50 6.400 0.122 1.9
L5 AAS1 6.50 6.40 6.30 6.60 6.60 6.480 0.130 2.0
L7 AAS1 6.87 6.85 6.87 6.78 6.68 6.810 0.082 1.2
L13 AAS1 6.56 6.55 7.00 6.56 6.60 6.654 0.194 2.9
L15 AAS1 6.63 6.62 6.42 6.95 6.57 6.638 0.194 2.9
L26 AAS1 [6.40] [6.13] [7.03] [5.90] [6.50] [6.392] [0.427] [6.7]
L56 AAS1 6.50 6.80 6.70 6.90 6.80 6.740 0.152 2.3
L63 AAS1 6.20 6.40 6.10 6.50 6.40 6.320 0.164 2.6
Means and 95% confidence intervals (CI)
µg/L
Method   LabId
  AAS1      L2
  AAS1     L56
  AAS1     L63
  AAS1      L5
  AAS1      L7
  AAS1     L13
  AAS1     L15
  AAS1     L26
  ASV1      L4
  ICP2      L4
[Means]   
5.0 5.2 5.4 5.6 5.8 6.0 6.2 6.4 6.6 6.8 7.0 7.2 7.4 7.6
Figure 12.4 - Graphical presentation of individual results BCR-635, Cd (µg/L)
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Table 12.e - Table of individual results for BCR-636, Pb (µg/L)
Lab ID Method Individual measurement results Mean Std. Dev. CV %
L1 FAAS2 479.00 476.00 506.00 495.00 512.00 493.600 15.947 3.2
L4 ASV1 532.00 538.00 545.00 532.00 530.00 535.400 6.148 1.1
L4 ICP2 525.00 540.00 519.00 537.00 530.00 530.200 8.585 1.6
L5 AAS1 534.50 537.50 543.00 531.50 535.00 536.300 4.310 0.8
L7 AAS1 537.60 496.00 503.30 494.00 505.10 507.200 17.631 3.5
L13 AAS1 511.00 490.00 511.00 513.00 498.00 504.600 10.114 2.0
L19 AAS2 519.00 522.00 541.00 520.00 534.00 527.200 9.783 1.9
L20 AAS2 515.90 540.80 520.00 532.50 505.60 522.960 13.868 2.7
L26 AAS1 504.00 495.00 490.00 509.00 457.00 491.00 20.408 4.2
L31 AAS1 509.32 498.25 523.90 507.02 505.29 508.756 9.422 1.9
L56 AAS1 510.00 515.00 505.00 510.00 517.00 511.400 4.722 0.9
Means and 95% confidence intervals (CI)
µg/L
Method   LabId
  AAS1     L31
  AAS1     L56
  AAS1     L26
  AAS1      L5
  AAS1      L7
  AAS1     L13
  AAS2     L20
  AAS2     L19
  ASV1      L4
 FAAS2      L1
  ICP2      L4
[Means]   
440 450 460 470 480 490 500 510 520 530 540 550 560 570
Figure 12.5 - Graphical presentation of individual results BCR- 636, Pb (µg/L)
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Table 12.f - Table of individual results for BCR-636, Cd (µg/L). Numbers in square
parantheses,“[ ]”, are statistically found outliers (significance level 1 %). They take part in the
Lillifors-test for normality and are shown in the graphs, but are ignored in all other
calculations.
Lab ID Method Individual measurement results Mean Std. Dev. CV %
L2 AAS1 12.20 12.51 11.24 12.15 12.50 12.120 0.519 4.3
L4 ASV1 10.80 10.30 11.20 11.30 11.40 11.000 0.453 4.1
L4 ICP2 11.00 11.50 11.10 11.30 11.20 11.220 0.192 1.7
L5 AAS1 11.20 11.40 11.70 11.50 11.70 11.500 0.212 1.8
L7 AAS1 11.98 12.00 12.03 12.00 11.80 11.962 0.092 0.8
L13 AAS1 11.56 11.96 12.03 11.79 11.56 11.780 0.219 1.9
L15 AAS1 11.30 11.37 11.52 11.93 11.31 11.486 0.263 2.3
L26 AAS1 [10.90] [10.00] [11.20] [12.40] [10.10] [10.920] [0.973] [8.9]
L56 AAS1 11.50 12.00 11.50 12.50 12.80 12.060 0.586 4.9
L63 AAS1 11.60 11.90 11.30 11.70 11.70 11.640 0.219 1.9
Means and 95% confidence intervals (CI)
µg/L
Method   LabId
  AAS1      L2
  AAS1     L56
  AAS1     L63
  AAS1      L5
  AAS1      L7
  AAS1     L13
  AAS1     L15
  AAS1     L26
  ASV1      L4
  ICP2      L4
[Means]   
8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0
Figure 12.6 - Graphical presentation of individual results BCR 636, Cd (µg/L)
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